𝔖 Bobbio Scriptorium
✦   LIBER   ✦

EORTC 24051: Unexpected side effects in a phase I study of TPF induction chemotherapy followed by chemoradiation with lapatinib, a dual EGFR/ErbB2 inhibitor, in patients with locally advanced resectable larynx and hypopharynx squamous cell carcinoma

✍ Scribed by Lalami, Yassine; Specenier, Pol M.; Awada, Ahmad; Lacombe, Denis; Liberatoscioli, Cecilia; Fortpied, Catherine; El-Hariry, Iman; Bogaerts, Jan; Andry, Guy; Langendijk, J.A.


Book ID
122853025
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
153 KB
Volume
105
Category
Article
ISSN
0167-8140

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES